AVITA Medical, Inc. (RCEL) Tops Q3 EPS by 10c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.34), $0.10 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• MediaTek Inc. (2454:TT) (MDTKF) PT Raised to NT$5,800 at Nomura/Instinet
• BofA is bearish on Indecies, sees shift to value stocks